<ol class="cite-this-references"><li id="reference-A290">Kanazawa S, Ohkubo T, Sugawara K: The effects of grapefruit juice on the pharmacokinetics of erythromycin. Eur J Clin Pharmacol. 2001 Jan-Feb;56(11):799-803. [<a href="/articles/A290" target="_blank">Article</a>] </li><li id="reference-A291">Ogwal S, Xide TU: Bioavailability and stability of erythromycin delayed release tablets. Afr Health Sci. 2001 Dec;1(2):90-6. [<a href="/articles/A291" target="_blank">Article</a>] </li><li id="reference-A292">Okudaira T, Kotegawa T, Imai H, Tsutsumi K, Nakano S, Ohashi K: Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans. J Clin Pharmacol. 2007 Jul;47(7):871-6. [<a href="/articles/A292" target="_blank">Article</a>] </li><li id="reference-A174445">Houin G, Tillement JP, Lhoste F, Rapin M, Soussy CJ, Duval J: Erythromycin pharmacokinetics in man. J Int Med Res. 1980;8 Suppl 2:9-14. [<a href="/articles/A174445" target="_blank">Article</a>] </li><li id="reference-A174448">Krasniqi S, Matzneller P, Kinzig M, Sorgel F, Huttner S, Lackner E, Muller M, Zeitlinger M: Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy. Antimicrob Agents Chemother. 2012 Feb;56(2):1059-64. doi: 10.1128/AAC.05490-11. Epub 2011 Nov 14. [<a href="/articles/A174448" target="_blank">Article</a>] </li><li id="reference-A174451">Amsden GW: Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther. 1996 Jan-Feb;18(1):56-72; discussion 55. [<a href="/articles/A174451" target="_blank">Article</a>] </li><li id="reference-A174454">Gordon RC, Regamey C, Kirby WM: Serum protein binding of erythromycin, lincomycin, and clindamycin. J Pharm Sci. 1973 Jul;62(7):1074-7. [<a href="/articles/A174454" target="_blank">Article</a>] </li><li id="reference-A174175">Fohner AE, Sparreboom A, Altman RB, Klein TE: PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. Pharmacogenet Genomics. 2017 Apr;27(4):164-167. doi: 10.1097/FPC.0000000000000270. [<a href="/articles/A174175" target="_blank">Article</a>] </li><li id="reference-A6505">Champney WS, Burdine R: Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus. Antimicrob Agents Chemother. 1995 Sep;39(9):2141-4. [<a href="/articles/A6505" target="_blank">Article</a>] </li><li id="reference-A14179">Champney WS, Miller M: Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin. Curr Microbiol. 2002 Jun;44(6):418-24. [<a href="/articles/A14179" target="_blank">Article</a>] </li><li id="reference-A174457">Sun H, Frassetto LA, Huang Y, Benet LZ: Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease. Clin Pharmacol Ther. 2010 Apr;87(4):465-72. doi: 10.1038/clpt.2009.247. Epub 2010 Jan 20. [<a href="/articles/A174457" target="_blank">Article</a>] </li><li id="reference-A174460">Franke RM, Lancaster CS, Peer CJ, Gibson AA, Kosloske AM, Orwick SJ, Mathijssen RH, Figg WD, Baker SD, Sparreboom A: Effect of ABCC2 (MRP2) transport function on erythromycin metabolism. Clin Pharmacol Ther. 2011 May;89(5):693-701. doi: 10.1038/clpt.2011.25. Epub 2011 Mar 30. [<a href="/articles/A174460" target="_blank">Article</a>] </li><li id="reference-A174193">Dinos GP: The macrolide antibiotic renaissance. Br J Pharmacol. 2017 Sep;174(18):2967-2983. doi: 10.1111/bph.13936. Epub 2017 Aug 10. [<a href="/articles/A174193" target="_blank">Article</a>] </li><li id="reference-A180595">Mather LE, Austin KL, Philpot CR, McDonald PJ: Absorption and bioavailability of oral erythromycin. Br J Clin Pharmacol. 1981 Aug;12(2):131-40. doi: 10.1111/j.1365-2125.1981.tb01191.x. [<a href="/articles/A180595" target="_blank">Article</a>] </li><li id="reference-A180598">Wang LQ, Hu ZY, Yu Q, Guo X, Xiong J, Huang ZZ, Cheng ZN: [Pharmacokinetics of erythromycin stinoprate capsule]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Apr;30(2):197-201. [<a href="/articles/A180598" target="_blank">Article</a>] </li><li id="reference-A180601">Colburn WA, Di Santo AR, Gibaldi M: Pharmacokinetics of erythromycin on repetitive dosing. J Clin Pharmacol. 1977 Oct;17(10 Pt 1):592-600. [<a href="/articles/A180601" target="_blank">Article</a>] </li><li id="reference-A180604">Barre J, Mallat A, Rosenbaum J, Deforges L, Houin G, Dhumeaux D, Tillement JP: Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity. Br J Clin Pharmacol. 1987 Jun;23(6):753-7. doi: 10.1111/j.1365-2125.1987.tb03111.x. [<a href="/articles/A180604" target="_blank">Article</a>] </li><li id="reference-A33081">Periti P, Mazzei T, Mini E, Novelli A: Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I). Clin Pharmacokinet. 1989 Apr;16(4):193-214. doi: 10.2165/00003088-198916040-00001. [<a href="/articles/A33081" target="_blank">Article</a>] </li><li id="reference-A180607">Kavi J, Webberley JM, Andrews JM, Wise R: A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycin. J Antimicrob Chemother. 1988 Jul;22 Suppl B:105-10. doi: 10.1093/jac/22.supplement_b.105. [<a href="/articles/A180607" target="_blank">Article</a>] </li><li id="reference-L5245">NIH StatPearls: Erythromycin [<a href="https://www.ncbi.nlm.nih.gov/books/NBK532249/" target="_blank">Link</a>] </li><li id="reference-L7261">FDA Approved Drug Products: Ery-Ped (erythromycin ethylsuccinate) granules for oral suspension [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050207s074,050611s036lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L7270">MedSafe NZ: ERA (erythromycin stearate) oral filmtabs [<a href="https://www.medsafe.govt.nz/Profs/Datasheet/e/ERAcaptab.pdf" target="_blank">Link</a>] </li><li id="reference-L7279">Pfizer: Erythromycin MSDS [<a href="https://www.pfizer.com/system/files/products/material_safety_data/PZ00645.pdf" target="_blank">Link</a>] </li><li id="reference-F3343">Erythromycin estolate monograph [<a href="//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/343/original/Erythromycin_Estolate.pdf?1549406070" target="_blank">File</a>] </li></ol>